ClinicalTrials.Veeva

Menu

De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery

University of Michigan logo

University of Michigan

Status

Enrolling

Conditions

Inguinal Hernia Repair
Laparoscopic Cholecystectomy
Breast Lumpectomy

Treatments

Behavioral: Active de-Implementation

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT06934564
R01HS029306 (U.S. AHRQ Grant/Contract)
HUM00261786

Details and patient eligibility

About

This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.

Enrollment

16 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Site

Inclusion Criteria:

  • Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair)

Exclusion Criteria:

  • none

Surgical participants must be over 18 years old.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

16 participants in 6 patient groups

Wave 1
Experimental group
Description:
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 2
Treatment:
Behavioral: Active de-Implementation
Wave 2
Experimental group
Description:
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 3
Treatment:
Behavioral: Active de-Implementation
Wave 3
Experimental group
Description:
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 4
Treatment:
Behavioral: Active de-Implementation
Wave 4
Experimental group
Description:
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 1
Treatment:
Behavioral: Active de-Implementation
Wave 5
Experimental group
Description:
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 2
Treatment:
Behavioral: Active de-Implementation
Wave 6
Experimental group
Description:
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 3
Treatment:
Behavioral: Active de-Implementation

Trial contacts and locations

1

Loading...

Central trial contact

Valerie Gavrila; Dana Greene Jr., MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems